Antimicrobial Resistance in the Food Chain Demands Faster, More Coherent Surveillance
Antimicrobial resistance is no longer confined to hospitals and outpatient prescribing. In the food chain, it moves through animals, water, processing environments, and ultimately toward consumers, creating a transmission network that connects veterinary medicine, environmental contamination, and human health in one continuous system. A One Health review by Gomes and colleagues frames that circulation as a surveillance problem as much as a microbiology problem: detection tools exist, but the technical and regulatory frameworks do not yet move at the same speed as the organismal threat.
The review centers on the food chain as a major route for resistance dissemination across animal agriculture, aquaculture, and food processing. That choice of scope matters because the microbial ecology in these settings differs sharply from the clinical setting where resistant organisms are often identified after infection has already occurred. In food systems, resistance can emerge under selective pressure from antimicrobial use, persist on surfaces and in biofilms, and travel through complex matrices that obscure direct laboratory detection. The result is a gap between what is present biologically and what current monitoring systems can reliably capture.
One sentence captures the central tension: the organisms are moving faster than the surveillance architecture.
Culture Testing Still Anchors Regulation, but It Misses Important Biology
The review places culture-based phenotypic testing in its familiar role as the regulatory gold standard. That method remains important because it answers a practical clinical and public health question: can the organism grow, and does it express resistance in a way that matters under standard conditions? For surveillance programs, that answer is still foundational, especially when regulatory decisions require reproducible results across laboratories and jurisdictions.
Yet culture has built-in blind spots. Some organisms enter a viable but non-culturable state, remaining biologically intact while eluding routine growth-based detection. In food matrices, that limitation becomes more consequential, because the sample itself can interfere with recovery and obscure the true burden of resistant organisms. Culture also offers a slower readout, which weakens its usefulness when public health systems need to track contamination events quickly enough to inform containment measures.
That lag is not just operational. It can delay recognition of contamination patterns that are already established in farm, processing, or distribution environments, allowing resistant strains to persist long enough to seed additional exposures.
Molecular Tools Offer Speed, But the Signal Is Not Always Straightforward
Against that backdrop, the review examines a set of rapidly evolving molecular methods, including Whole Genome Sequencing, metagenomics, and emerging CRISPR-Cas diagnostics. These platforms offer a different kind of surveillance. Instead of waiting for visible growth and phenotypic confirmation, they can identify genetic determinants of resistance, map strain relatedness, and detect microbial communities in ways that are difficult or impossible for standard culture to match.
Whole Genome Sequencing carries particular value because it can link resistance genes with broader genomic context. In a food safety investigation, that level of resolution supports source tracking and outbreak reconstruction. Metagenomics extends the view even further by sampling genetic material directly from complex environments, which is especially relevant in settings where multiple organisms coexist and some cannot be readily cultured. CRISPR-Cas diagnostics sit at the newer edge of the field, promising rapid and targeted detection with the potential for streamlined testing workflows.
Speed, however, does not solve the hardest interpretive problem. The review reporting matrix interference and the genotype-phenotype disconnect as major barriers. A resistance gene may be present without producing the expected clinical or phenotypic behavior under the tested conditions. Conversely, a phenotypic result may reflect regulatory pathways, environmental pressures, or stress responses that are not captured by sequence data alone. This disconnect matters because surveillance systems need answers that are not just fast, but actionable and biologically meaningful.
Why the Food Matrix Complicates Every Layer of Detection
Food is not a neutral sampling medium. Proteins, fats, microbial communities, processing residues, and biofilm structures can all distort detection. That complexity affects both traditional and molecular assays. In phenotypic testing, the matrix can impede recovery and growth. In molecular workflows, it can inhibit amplification, dilute target material, or complicate interpretation when resistance determinants are embedded in mixed communities rather than isolated organisms.
Aquaculture and animal agriculture add another layer of complexity because they sit at the interface of environmental exposure and managed antimicrobial use. Resistant organisms can circulate between water, soil, feed, animal gut flora, and processing surfaces. Once biofilms form, they act as protected microbial reservoirs, making eradication far harder than surface disinfection alone would suggest. Control strategies therefore need to address not only the organism, but the ecological niche that protects it.
Surveillance Without Mitigation Only Documents the Problem
Gomes and colleagues do not treat detection as an isolated laboratory exercise. The review also describes integrated mitigation strategies that start on the farm and continue through processing and consumer handling. Antimicrobial stewardship in animal production remains central, because every unnecessary exposure increases selective pressure and broadens the field for resistance emergence. Biofilm control adds another practical layer, especially in processing environments where persistent microbial communities can undermine routine sanitation.
Consumer hygiene remains part of the chain as well. Food handling practices cannot reverse upstream resistance, but they can interrupt downstream transmission and reduce the chance that contaminated products become a human exposure event. The review’s One Health perspective is important precisely because it avoids false separation between farm, factory, and kitchen. Resistant organisms do not respect those boundaries, and surveillance programs that stop at a single node will miss much of the movement.
Regulatory Systems Need a Better Bridge Between Biology and Decision-Making
The review’s most consequential argument is not that one assay should replace another. It is that the field needs a bridge between fast molecular insight and the standards required for regulatory action. Culture remains valuable for validation and comparability. Molecular diagnostics offer sensitivity, speed, and depth. The problem is the absence of a seamless framework that tells laboratories, regulators, and public health agencies how to combine those outputs into a single coherent response.
Without that bridge, AMR surveillance can generate data that are technically impressive but operationally incomplete. A genome sequence may identify resistance genes, yet still leave uncertainty about expression, viability, or food-chain relevance. A culture result may confirm phenotypic resistance, yet fail to detect organisms that are present but unculturable. The review argues for closing exactly those gaps, because effective intervention depends on seeing the resistant organism clearly enough to act before it moves farther through the chain.
What remains unresolved is not whether food-chain AMR matters. It does. The unresolved issue is how quickly surveillance systems can adapt their methods, validation standards, and intervention logic to match the biology already in motion.